Bsteh G - Search Results

1

Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis.

Krajnc N, Dal-Bianco A, Leutmezer F, Kasprian G, Pemp B, Kornek B, Berger T, Rommer PS, Hametner S, Lassmann H, Bsteh G. Krajnc N, et al. Among authors: bsteh g. Mult Scler. 2023 Mar;29(3):374-384. doi: 10.1177/13524585221138486. Epub 2022 Dec 20. Mult Scler. 2023. PMID: 36537667

2

New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.

Toboso I, Tejeda-Velarde A, Alvarez-Lafuente R, Arroyo R, Hegen H, Deisenhammer F, Sainz de la Maza S, Alvarez-Cermeño JC, Izquierdo G, Paramo D, Oliva P, Casanova B, Agüera-Morales E, Franciotta D, Gastaldi M, Fernández O, Urbaneja P, Garcia-Dominguez JM, Romero F, Laroni A, Uccelli A, Perez-Sempere A, Saiz A, Blanco Y, Galimberti D, Scarpini E, Espejo C, Montalban X, Rasche L, Paul F, González I, Álvarez E, Ramo C, Caminero AB, Aladro Y, Calles C, Eguía P, Belenguer-Benavides A, Ramió-Torrentà L, Quintana E, Martínez-Rodríguez JE, Oterino A, López de Silanes C, Casanova LI, Landete L, Frederiksen J, Bsteh G, Mulero P, Comabella M, Hernández MA, Espiño M, Prieto JM, Pérez D, Otano M, Padilla F, García-Merino JA, Navarro L, Muriel A, Frossard LC, Villar LM. Toboso I, et al. Among authors: bsteh g. Front Neurol. 2020 Dec 17;11:579438. doi: 10.3389/fneur.2020.579438. eCollection 2020. Front Neurol. 2020. PMID: 33408681 Free PMC article.

3

NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.

Ramberger M, Bsteh G, Schanda K, Höftberger R, Rostásy K, Baumann M, Aboulenein-Djamshidian F, Lutterotti A, Deisenhammer F, Berger T, Reindl M. Ramberger M, et al. Among authors: bsteh g. Neurol Neuroimmunol Neuroinflamm. 2015 Aug 13;2(5):e141. doi: 10.1212/NXI.0000000000000141. eCollection 2015 Oct. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 26309901 Free PMC article.

4

Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.

Bsteh G, Ehling R, Lutterotti A, Hegen H, Di Pauli F, Auer M, Deisenhammer F, Reindl M, Berger T. Bsteh G, et al. PLoS One. 2016 Jul 8;11(7):e0158978. doi: 10.1371/journal.pone.0158978. eCollection 2016. PLoS One. 2016. PMID: 27391947 Free PMC article.

5

Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.

Ehling R, Bsteh G, Di Pauli F, Hegen H, Auer M, Obermair K, Wagner M, Deisenhammer F, Reindl M, Berger T. Ehling R, et al. Among authors: bsteh g. Mult Scler Relat Disord. 2016 Sep;9:150-4. doi: 10.1016/j.msard.2016.07.014. Epub 2016 Jul 27. Mult Scler Relat Disord. 2016. PMID: 27645364

6

Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors.

Bsteh G, Feige J, Ehling R, Auer M, Hegen H, Di Pauli F, Deisenhammer F, Reindl M, Berger T. Bsteh G, et al. Mult Scler. 2017 Aug;23(9):1241-1248. doi: 10.1177/1352458516675751. Epub 2016 Oct 20. Mult Scler. 2017. PMID: 27765877

7

Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study.

Hegen H, Auer M, Bsteh G, Di Pauli F, Plavina T, Walde J, Deisenhammer F, Berger T. Hegen H, et al. Among authors: bsteh g. PLoS One. 2017 Mar 20;12(3):e0174005. doi: 10.1371/journal.pone.0174005. eCollection 2017. PLoS One. 2017. PMID: 28319193 Free PMC article.

8

Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis-The PaSiMS II study.

Bsteh G, Ehling R, Walchhofer LM, Hegen H, Auer M, Wurth S, Di Pauli F, Wagner M, Reindl M, Deisenhammer F, Berger T. Bsteh G, et al. PLoS One. 2017 Jul 27;12(7):e0181458. doi: 10.1371/journal.pone.0181458. eCollection 2017. PLoS One. 2017. PMID: 28749974 Free PMC article.

9

Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.

Wurth S, Kuenz B, Bsteh G, Ehling R, Di Pauli F, Hegen H, Auer M, Gredler V, Deisenhammer F, Reindl M, Berger T. Wurth S, et al. Among authors: bsteh g. PLoS One. 2017 Aug 4;12(8):e0182462. doi: 10.1371/journal.pone.0182462. eCollection 2017. PLoS One. 2017. PMID: 28777826 Free PMC article.

10

Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis.

Bsteh G, Hegen H, Teuchner B, Amprosi M, Berek K, Ladstätter F, Wurth S, Auer M, Di Pauli F, Deisenhammer F, Berger T. Bsteh G, et al. Mult Scler. 2019 Feb;25(2):196-203. doi: 10.1177/1352458517740216. Epub 2017 Nov 2. Mult Scler. 2019. PMID: 29095097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters